中红医疗：10月28日召开董事会会议

Group 1 - The core point of the article highlights that Zhonghong Medical (SZ 300981) announced the convening of its 13th meeting of the fourth board of directors on October 28, 2025, via telecommunication, where it reviewed proposals including the revision of relevant systems [1] - For the first half of 2025, Zhonghong Medical's revenue composition is entirely from the medical device industry, accounting for 100.0% [1] Group 2 - The A-share market has surpassed 4000 points, marking a significant resurgence after a decade of stagnation, with technology leading the market's transformation into a new "slow bull" pattern [1]